Clinical trial
Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00019188 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019188 |
|---|---|
| Title | Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma |
| Official title | Phase I/II Pilot Study of Interleukin-12 in Patients With AIDS-Associated Kaposi's Sarcoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Epidemic Kaposi's Sarcoma, Recurrent Kaposi's Sarcoma |
| Intervention type | Drug |
| Interventions | interleukin-12 |
| Start date | Jan 1, 1997 |
| Completion | Mar 1, 2007 |
| First posted | Mar 5, 2007 |
| Last update posted | Mar 4, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: